nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comment on Hunt et al, “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”
|
Yavas, Guler |
|
|
28 |
C |
p. 88-89 |
artikel |
2 |
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis
|
Chiloiro, Giuditta |
|
|
28 |
C |
p. 1-9 |
artikel |
3 |
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial
|
Thomsen, M.S. |
|
|
28 |
C |
p. 118-123 |
artikel |
4 |
European radiation oncology after one year of COVID-19 pandemic
|
Slotman, Ben J. |
|
|
28 |
C |
p. 141-143 |
artikel |
5 |
Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature
|
Hafeez, Neha |
|
|
28 |
C |
p. 129-132 |
artikel |
6 |
In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors
|
Sabater, Sebastià |
|
|
28 |
C |
p. 116-117 |
artikel |
7 |
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience
|
Jethwa, Krishan R. |
|
|
28 |
C |
p. 17-23 |
artikel |
8 |
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
|
Mul, Joeri |
|
|
28 |
C |
p. 39-47 |
artikel |
9 |
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA)
|
Krug, David |
|
|
28 |
C |
p. 90-96 |
artikel |
10 |
Overall survival nomogram for patients with spinal bone metastases (SBM)
|
Osong, Biche |
|
|
28 |
C |
p. 48-53 |
artikel |
11 |
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer
|
Haslett, K. |
|
|
28 |
C |
p. 24-31 |
artikel |
12 |
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study
|
Jing, Wang |
|
|
28 |
C |
p. 54-61 |
artikel |
13 |
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point
|
Kotha, Nikhil V. |
|
|
28 |
C |
p. 133-140 |
artikel |
14 |
Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution
|
Vakaet, Vincent |
|
|
28 |
C |
p. 10-16 |
artikel |
15 |
Radiomic biomarkers of tumor immune biology and immunotherapy response
|
Wang, Jarey H. |
|
|
28 |
C |
p. 97-115 |
artikel |
16 |
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study
|
Altay-Langguth, Alev |
|
|
28 |
C |
p. 71-78 |
artikel |
17 |
Stereotactic lung reirradiation for local relapse: A case series
|
Kinj, Rémy |
|
|
28 |
C |
p. 85-87 |
artikel |
18 |
The effect of low-dose radiation spillage during stereotactic radiosurgery for brain metastases on the development of de novo metastases
|
Paul, Shiby |
|
|
28 |
C |
p. 79-84 |
artikel |
19 |
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset
|
in 't Ven, Lieke |
|
|
28 |
C |
p. 32-38 |
artikel |
20 |
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?
|
Ryckman, Jeffrey M. |
|
|
28 |
C |
p. 124-128 |
artikel |
21 |
Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma
|
Fatima, Kashuf |
|
|
28 |
C |
p. 62-70 |
artikel |